BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6085017)

  • 1. [Administration of anticancer agents into the pleural lymphatics and mediastinal lymph nodes during thoracotomy].
    Ueno Y
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):64-72. PubMed ID: 6085017
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of extended lymph nodes dissection on curative resection of lung cancer].
    Li Y; Li H; Hu Y
    Zhonghua Wai Ke Za Zhi; 1997 Jun; 35(6):357-9. PubMed ID: 10374472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
    Huang GJ; Fang DK; Cheng GY; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An experimental study on intralymphatic anti cancer chemotherapy].
    Ueno Y
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):50-63. PubMed ID: 6085016
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metastases to the mediastinal lymph nodes in lung cancer and their extensive dissection].
    Li Y; Li H; Hu Y
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):303-5. PubMed ID: 11038766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node metastasis of T1, T2 squamous carcinoma and adenocarcinoma of lung: characteristics and clinical significance.
    Li Y; Liu H; Li H; Hu Y; Yin H; Wang Z
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):725-7. PubMed ID: 11832148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on the mediastinal lymphangiography and intralymphatic chemotherapy].
    Mitani N
    Igaku Kenkyu; 1983 Dec; 53(6):376-96. PubMed ID: 6206678
    [No Abstract]   [Full Text] [Related]  

  • 8. Lung cancer and skeletal muscle metastases.
    Di Giorgio A; Sammartino P; Cardini CL; Al Mansour M; Accarpio F; Sibio S; Di Seri M
    Ann Thorac Surg; 2004 Aug; 78(2):709-11. PubMed ID: 15276559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.
    Livingston RB; Mira J; O'Bryan RM
    Cancer Treat Rep; 1981; 65(1-2):143-4. PubMed ID: 6164484
    [No Abstract]   [Full Text] [Related]  

  • 10. [T1, T2 squamous or adenocarcinoma of the lung:characteristics of lymph node metastasis and its clinical significance].
    Li Y; Liu H; Li H; Hu Y; Yin H
    Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):432-4. PubMed ID: 11832076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rational lymph node dissection for lung cancer according to the occurrence lobe and histological type].
    Ota S; Inaba H; Yoshida H
    Kyobu Geka; 2001 Dec; 54(13):1073-8; discussion 1078-81. PubMed ID: 11761888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An experimental study in pulmonary and mediastinal lymph flows. The technic of blocking mediastinal lymph flows to the contralateral side and the intralymphatic administration of anti-cancer agents to bilateral mediastinal lymph nodes].
    Arimura T
    Nihon Kyobu Geka Gakkai Zasshi; 1984 Feb; 32(2):131-43. PubMed ID: 6205103
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental and clinical analysis of the adjuvant chemotherapy of lung cancer via lymphatic route during operation].
    Mitani N; Shimotakahara T; Sanno K; Arimura T; Nishijima H; Baba K; Tanaka T; Kajisa T
    Kyobu Geka; 1986 Jan; 39(1):29-33. PubMed ID: 2422425
    [No Abstract]   [Full Text] [Related]  

  • 17. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
    Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.